Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancer
Noemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, Meera Warby, Loretta M S Lau, Marie Wong-Erasmus, Dong-Anh Khuong-Quang, Paulette Barahona, Bhavna Padhye, Sam El-Kamand, Sheena Nunag, Pamela Ajuyah, Alexandra Sherstyuk, Ann-Kristin Altekoester, Ashleigh Sullivan, Nicola Poplawski, Catherine Kiraly-Borri, Sarah O’Sullivan, Helen Marfan, Rozanna Alli, Lisette Curnow, Kanika Bhatia, Antoinette Anazodo, Toby N Trahair, Marion Mateos, Jordan R. Hansford, Hetal Dholaria, Sarah Josephi-Taylor, Andrew S Moore, Wayne Nicholls, Nicholas G Gottardo, Peter Downie, Seong-Lin Khaw, Heather Tapp, Geoffrey McCowage, Luciano Dalla-Pozza, Frank Alvaro, Paul J Wood, Vanessa Tyrrell, Michelle Haber, Mark J Cowley, Paul G Ekert, Glenn M Marshall, Judy Kirk, Katherine Tucker, Mark Pinese, David S Ziegler
medRxiv 2024.08.08.24311493; doi: https://doi.org/10.1101/2024.08.08.24311493
